Fetal HLA-G mediated immune tolerance and interferon response in preeclampsia
Eero Kajantie; Erik Iwarsson; Inka M. Häkkinen; Mika Gissler; Hannu Sariola; Mikael Mokkonen; Seppo Heinonen; Nina Linder; Masahito Yoshihara; Juho Wedenoja; Satu Wedenoja; Ellika Sahlin; Tiina Skoog; Hindrek Tederd; Hannele Laivuori; Kaarel Krjutškov; Karin Pettersson; Johan Lundin; Shintaro Katayama; Juha Kere; Sini Ezer
Fetal HLA-G mediated immune tolerance and interferon response in preeclampsia
Eero Kajantie
Erik Iwarsson
Inka M. Häkkinen
Mika Gissler
Hannu Sariola
Mikael Mokkonen
Seppo Heinonen
Nina Linder
Masahito Yoshihara
Juho Wedenoja
Satu Wedenoja
Ellika Sahlin
Tiina Skoog
Hindrek Tederd
Hannele Laivuori
Kaarel Krjutškov
Karin Pettersson
Johan Lundin
Shintaro Katayama
Juha Kere
Sini Ezer
ELSEVIER
Julkaisun pysyvä osoite on:
https://urn.fi/URN:NBN:fi-fe2021042821509
https://urn.fi/URN:NBN:fi-fe2021042821509
Tiivistelmä
Background: Fetal immune tolerance is crucial for pregnancy success. We studied the link between preeclampsia, a severe pregnancy disorder with uncertain pathogenesis, and fetal human leukocyte antigen G (HLA-G) and other genes regulating maternal immune responses.
Methods: We assessed sex ratios and regulatory HLA-G haplotypes in population cohorts and series of preeclampsia and stillbirth. We studied placental mRNA expression of 136 genes by sequencing and HLA-G and interferon alpha (IFN alpha) protein expression by immunohistochemistry.
Findings: We found underrepresentation of males in preeclamptic births, especially those delivered preterm or small for gestational age. Balancing selection at HLA-G associated with the sex ratio, stillbirth, and preeclampsia. We observed downregulation of HLA-G, its receptors, and many other tolerogenic genes, and marked upregulation of IFNA1 in preeclamptic placentas.
Interpretation: These findings indicate that an evolutionary trade-off between immune tolerance and protection against infections at the maternal-fetal interface promotes genetic diversity in fetal HLA-G, thereby affecting survival, preeclampsia, and sex ratio. We highlight IFNA1 as a potential mediator of preeclampsia and a target for therapeutic trials. (C) 2020 The Authors. Published by Elsevier B.V.
Kokoelmat
- Rinnakkaistallenteet [19207]